| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |